Related Experiment Videos
Common gene polymorphisms, cancer progression and prognosis
1MRC Dunn Human Nutrition Unit, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 2XY, UK. alex1@supanet.com
Cancer Letters
|April 24, 2004
Summary
Genetic variations, or polymorphisms, significantly influence tumor growth and patient outcomes by affecting normal cellular processes. Understanding these genetic factors is crucial for predicting disease progression and optimizing cancer therapy.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Neoplastic growth was traditionally viewed as an autonomous process.
- Emerging evidence highlights the utilization of normal regulatory and metabolic mechanisms by tumors.
- Normal genetic variation plays a critical role in neoplastic growth and disease outcomes.
Purpose of the Study:
- To review gene polymorphisms impacting post-initiation stages of tumor development.
- To explore polymorphisms affecting cellular growth control, invasion, metastasis, hormone/vitamin action, and cancer therapy outcomes.
- To emphasize the prognostic significance of genetic variation in cancer.
Main Methods:
- Review of scientific literature on gene polymorphisms in cancer.
- Focus on polymorphisms affecting key biological processes in tumor development.
- Analysis of studies related to cancer pharmacogenetics.
Main Results:
- Gene polymorphisms influence cell proliferation, differentiation, and death.
- Polymorphisms affect tumor invasion, metastasis, immune response, and angiogenesis.
- Genetic variations impact hormone/vitamin action and cancer treatment efficacy (pharmacogenetics).
Conclusions:
- Normal genetic variation is a major determinant of neoplastic growth and disease outcome.
- While promising, research on gene polymorphisms in cancer requires larger studies with robust statistical power.
- Integrated analysis of gene groups within metabolic pathways holds potential for identifying prognostic polymorphism profiles.